Arvid Carlsson
Swedish neuroscientist
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist. He was best known for his work with the neurotransmitter dopamine and its effects on Parkinson's disease.
Arvid Carlsson | |
|---|---|
 | |
| Born | 25 January 1923 Uppsala, Sweden |
| Died | 29 June 2018 (aged 95) Gothenburg, Sweden |
| Nationality | Swedish |
| Alma mater | Lund University |
| Known for | Dopamine |
| Awards | Nobel Prize in Physiology or Medicine (2000) |
He won the Wolf Prize in Medicine in 1979. He was elected a member of the Academia Europaea in 1989.[1]
For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000.[2] He won the award alongside Eric Kandel and Paul Greengard.
References
change- ↑ "Arvid Carlsson". Academia Europaea. Archived from the original on 28 March 2019.
- ↑ Barondes, Samuel H. (2003). Better Than Prozac. New York: Oxford University Press. pp. 21–22, 39–40. ISBN 0-19-515130-5.
Other websites
change
This short article about a person or group of people can be made longer. You can help Wikipedia by adding to it.